OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.415
+0.015 (1.07%)
At close: Nov 6, 2026, 4:00 PM EST
1.410
-0.005 (-0.35%)
After-hours: Nov 6, 2026, 6:29 PM EST
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $74.26 million as of November 6, 2026. It is the 27,089th most valuable company in the world and the 4,298th biggest in the United States. Its market cap has decreased by 27.41% in one year.
Market Cap
74.26M
Enterprise Value
53.66M
1-Year Change
-27.41%
Global Rank
Country Rank
#4,298 United States
Category
ChartMarket Cap Chart
Since the IPO on May 17, 2022, OKYO Pharma's market cap has decreased from $86.61M to $74.26M, a decrease of -14.26%. That is a compound annual growth rate of -3.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 74.26M | -4.62% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -50.99% |
| May 17, 2022 | 86.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 79.44M |
| NeOnc Technologies Holdings | 76.43M |
| Nutriband | 75.55M |
| MediciNova | 71.86M |
| Acrivon Therapeutics | 70.92M |
| Corbus Pharmaceuticals Holdings | 70.40M |
| Coya Therapeutics | 70.37M |
| Cognition Therapeutics | 68.19M |